Zurich Cantonal Bank’s AstraZeneca AZN Stock Holding History

Zurich Cantonal Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$386M	Buy	+1,992,762	New	+$384M	0.84%	16
2025 Q3	–	Sell	-75	Closed	-$10.5K	–	2553
2025 Q2	$10.5K	Hold	75	–	–	﹤0.01%	2516
2025 Q1	$11K	Hold	75	–	–	﹤0.01%	2588
2024 Q4	$9.83K	Hold	75	–	–	﹤0.01%	2608
2024 Q3	$11.7K	Hold	75	–	–	﹤0.01%	2610
2024 Q2	$11.7K	Hold	75	–	–	﹤0.01%	2613
2024 Q1	$10.2K	Sell	75 -2,471	-97%	-$327K	﹤0.01%	2650
2023 Q4	$343K	Buy	2,546 +1,537	+152%	+$200K	﹤0.01%	1758
2023 Q3	$137K	Hold	1,009	–	–	﹤0.01%	2196
2023 Q2	$144K	Hold	1,009	–	–	﹤0.01%	2128
2023 Q1	$140K	Sell	1,009 -76	-7%	-$10.2K	﹤0.01%	2087
2022 Q4	$147K	Sell	1,085 -4,861	-82%	-$610K	﹤0.01%	2018
2022 Q3	$652K	Hold	5,946	–	–	﹤0.01%	1022
2022 Q2	$786K	Buy	5,946 +643	+12%	+$84.4K	﹤0.01%	962
2022 Q1	$704K	Buy	5,303 +266	+5%	+$31.9K	﹤0.01%	1123
2021 Q4	$587K	Hold	5,037	–	–	﹤0.01%	1325
2021 Q3	$605K	Buy	+5,037	New	+$586K	﹤0.01%	1175

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Zurich Cantonal Bank's AZN Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in AstraZeneca (AZN) in Q1 2026: 1,992,762 shares worth $386M. The stake represents 0.84% of the portfolio and ranks #16 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AZN as recently as Q2 2025.

Zurich Cantonal Bank first reported a position in AZN in Q3 2021 and has held it in 17 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Zurich Cantonal Bank held 1,992,762 shares of AstraZeneca worth $386M as of Q1 2026.
AstraZeneca was a new Zurich Cantonal Bank position in Q1 2026.
AstraZeneca made up 0.84% of Zurich Cantonal Bank's portfolio in Q1 2026, its #16 holding.
Zurich Cantonal Bank first reported a position in AstraZeneca in Q3 2021 and has held it in 17 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.